Gender leadership in gynecologic oncology professional societies worldwide

Int J Gynaecol Obstet. 2023 Oct;163(1):154-157. doi: 10.1002/ijgo.14890. Epub 2023 May 23.

Abstract

Objective: We aim to study gender representation among the different national gynecologic oncology (GO) societies' presidents over the past decade.

Methods: A cross-sectional study examining the period 2013-2022. The leadership positions in 11 GO societies in the USA (SGO), internationally (IGCS), Europe (ESGO), Australia (ASGO), Israel (ISGO), Japan (JSGO), Asia-Oceania (AOGIN), India (INSGO), Latin America (SLAGO), South Africa (SASGO), and Turkey (TRSGO) was studied. The proportion of leadership positions held by women was calculated and trends were evaluated.

Results: Overall, the average rate of women's representation during the study period was 26.4%, and for the different organizations was: SASGO 70.0%, SGO 50.0%, ESGO 40.0%, ASGO 30.0%, INSGO 30.0%, and IGCS, ISGO, and SLAGO 20.0% each, TRSGO 10%, and no representation of women in JSGO and AOGIN. There was a significant decrease from 2013 to 2016 (63.6% to 9.1%) (P = 0.009) in women's representation as presidents of societies. From 2017 to 2022, there was no difference in women's representation (ranging from 9.1% to 36.4%) (P = 0.13).

Conclusions: This study demonstrates that women are significantly under-represented in leadership positions in GO professional societies; however, in South Africa and the USA their representation in the last decade was close to equality.

Keywords: gender equality; gender leadership; gynecologic oncology; professional societies; women leadership.

MeSH terms

  • Australia
  • Cross-Sectional Studies
  • Female
  • Gender Identity
  • Genital Neoplasms, Female*
  • Humans
  • Leadership*
  • Societies, Medical